submit urlsubmit rss feedadd directoryphysician directoryPharmacology opportunity

article

Busulfan is a chemotherapy drug that is an alkylating agent (slows the growth of cancer cells). It is marketed in the US by GlaxoSmithKline under the brand name Myleran, and has been in clinical use since 1959. Currently, its main uses are in bone marrow transplantation, especially in Chronic myelogenous leukemia (CML), where it is used as a conditioning drug. Toxicity may include pulmonary fibrosis and hyperpigmentation.

Busulfan also induces thrombocytopenia, a condition of lowered blood platelet count and activity. The drug was recently used in a study (published April 2006, Science) to examine the role of platelet-transported serotonin in liver regeneration.

External links


More on [ Busulfan ]


directory of related categories

 
Busulfan RSS feed
Busulfan - Twitter Search

Like every UTAK control, our Busulfan controls come with our exclusive no-nonsense guarantee and our extraordinary personal customer service
utaklabs (UTAK Laboratories) Thu, 26 Jan 2012 00:16:58 -0000
Like every UTAK control, our Busulfan controls come with our exclusive no-nonsense guarantee and our extraordinary personal customer service
Like every UTAK control, our Busulfan controls come with our exclusive no-nonsense guarantee and our extraordinary personal customer service
UTAK_LABS (UTAK Laboratories) Thu, 26 Jan 2012 00:16:25 -0000
Like every UTAK control, our Busulfan controls come with our exclusive no-nonsense guarantee and our extraordinary personal customer service
Busulfan RSS feed

directory of related sites

MedlinePlus: Busulfan - Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations.
Meta Description: [ Busulfan ]

Busulfan related videos

 

HOMEADVERTISINGABOUT US

articlesartsbusinesscomputersgameshealthhospitalshomekids & teensnewsmobilephysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld


Submit a Site About Become an Editor